Clinical utility of diagnostic biomarkers in malignant pleural mesothelioma: a systematic review and meta-analysis

Malignant pleural mesothelioma (MPM) is characterised by late-stage diagnosis and poor prognosis. Currently, no screening tool is advocated and diagnosis is based on invasive techniques, which are not well tolerated. Non-invasive diagnostic biomarkers have shown potential and could have a huge clini...

Descripción completa

Detalles Bibliográficos
Autores principales: Schillebeeckx, Eline, van Meerbeeck, Jan P., Lamote, Kevin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2021
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489015/
https://www.ncbi.nlm.nih.gov/pubmed/34789461
http://dx.doi.org/10.1183/16000617.0057-2021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489015/
https://www.ncbi.nlm.nih.gov/pubmed/34789461
http://dx.doi.org/10.1183/16000617.0057-2021

Ejemplares similares